2024 Q2 Form 10-Q Financial Statement

#000079929224000039 Filed on April 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.110B $1.047B
YoY Change 9.44% 4.61%
Cost Of Revenue $800.5M $763.4M
YoY Change 5.91% -0.33%
Gross Profit $309.3M $283.3M
YoY Change 19.79% 20.76%
Gross Profit Margin 27.87% 27.07%
Selling, General & Admin $122.5M $110.0M
YoY Change 13.92% 9.98%
% of Gross Profit 39.6% 38.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.799M $3.304M
YoY Change 5.62% 2.8%
% of Gross Profit 1.23% 1.17%
Operating Expenses $122.5M $110.0M
YoY Change 13.92% 9.98%
Operating Profit $186.8M $173.3M
YoY Change 23.98% 28.78%
Interest Expense $7.348M $6.920M
YoY Change 56.41% 395.7%
% of Operating Profit 3.93% 3.99%
Other Income/Expense, Net
YoY Change
Pretax Income $194.1M $180.2M
YoY Change 24.96% 32.55%
Income Tax $47.40M $42.20M
% Of Pretax Income 24.42% 23.41%
Net Earnings $146.7M $138.1M
YoY Change 24.36% 33.95%
Net Earnings / Revenue 13.22% 13.19%
Basic Earnings Per Share $5.26 $4.92
Diluted Earnings Per Share $5.12 $4.78
COMMON SHARES
Basic Shares Outstanding 27.75M shares 27.81M shares
Diluted Shares Outstanding 28.67M shares 28.89M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $837.5M $870.2M
YoY Change 25.31% 60.38%
Cash & Equivalents $837.5M $870.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $2.938B $2.774B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.776B $3.644B
YoY Change 12.54% 13.89%
LONG-TERM ASSETS
Property, Plant & Equipment $36.44M $33.15M
YoY Change -61.19% -11.42%
Goodwill $16.40M $16.40M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $46.18M $59.15M
YoY Change 9.98% 20.63%
Other Assets $242.6M $250.4M
YoY Change 16.14% 2.33%
Total Long-Term Assets $564.1M $567.6M
YoY Change 11.39% 0.93%
TOTAL ASSETS
Total Short-Term Assets $3.776B $3.644B
Total Long-Term Assets $564.1M $567.6M
Total Assets $4.340B $4.212B
YoY Change 12.39% 11.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $278.9M $225.0M
YoY Change 5.37% 7.94%
Accrued Expenses $58.04M $59.16M
YoY Change -2.38% -2.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $336.9M $284.1M
YoY Change -20.2% -22.58%
LONG-TERM LIABILITIES
Long-Term Debt $917.2M $918.4M
YoY Change 4.28% 0.22%
Other Long-Term Liabilities $344.9M $370.6M
YoY Change 31.84% 25.32%
Total Long-Term Liabilities $1.262B $1.289B
YoY Change 10.6% 6.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $336.9M $284.1M
Total Long-Term Liabilities $1.262B $1.289B
Total Liabilities $1.599B $1.573B
YoY Change 2.28% -0.38%
SHAREHOLDERS EQUITY
Retained Earnings $2.586B $2.439B
YoY Change 25.72% 25.8%
Common Stock $350.9M $348.3M
YoY Change 0.12% -0.56%
Preferred Stock
YoY Change
Treasury Stock (at cost) $195.9M $149.0M
YoY Change 79.69% 40.37%
Treasury Stock Shares
Shareholders Equity $2.741B $2.639B
YoY Change
Total Liabilities & Shareholders Equity $4.340B $4.212B
YoY Change 12.39% 11.95%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $146.7M $138.1M
YoY Change 24.36% 33.95%
Depreciation, Depletion And Amortization $3.799M $3.304M
YoY Change 5.62% 2.8%
Cash From Operating Activities $27.51M $115.8M
YoY Change -83.45% -53.97%
INVESTING ACTIVITIES
Capital Expenditures $5.494M $276.0K
YoY Change 12676.74% -86.72%
Acquisitions
YoY Change
Other Investing Activities -$4.939M -$16.83M
YoY Change -342.82% 520.19%
Cash From Investing Activities -$10.43M -$17.11M
YoY Change -624.01% 256.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -49.78M $38.69M
YoY Change 17.25% -346.71%
NET CHANGE
Cash From Operating Activities 27.51M $115.8M
Cash From Investing Activities -10.43M -$17.11M
Cash From Financing Activities -49.78M $38.69M
Net Change In Cash -32.70M $137.4M
YoY Change -126.01% -40.54%
FREE CASH FLOW
Cash From Operating Activities $27.51M $115.8M
Capital Expenditures $5.494M $276.0K
Free Cash Flow $22.02M $115.5M
YoY Change -86.75% -53.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 mho Equityinvestedin Ll Cs
EquityinvestedinLLCs
5600000 usd
CY2023Q4 mho Equityinvestedin Ll Cs
EquityinvestedinLLCs
5600000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1000000.0 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1000000.0 usd
CY2024Q1 mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.97 rate
CY2023Q1 mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.97 rate
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
763360000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
765904000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56084000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50960000 usd
CY2024Q1 us-gaap Selling Expense
SellingExpense
53940000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
49080000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000 usd
CY2024Q1 mho Interest Income Net Of Interest Expense
InterestIncomeNetOfInterestExpense
6920000 usd
CY2023Q1 mho Interest Income Net Of Interest Expense
InterestIncomeNetOfInterestExpense
1389000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
866464000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
864548000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
180239000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
135982000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42178000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32916000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
138061000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
103066000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.92
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.73
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.78
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.64
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28052000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27602000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28888000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28305000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2516939000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
138061000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5495000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3539000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25278000 usd
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
29000 usd
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2638785000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2070725000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103066000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6439000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2023000 usd
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
962000 usd
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2183215000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
138061000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
103066000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
542564000 usd
CY2024Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
600946000 usd
CY2023Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
494461000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
539379000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
514346000 usd
CY2024Q1 mho Fair Value Adjustment Of Mortgage Loans Held For Sale
FairValueAdjustmentOfMortgageLoansHeldForSale
2849000 usd
CY2023Q1 mho Fair Value Adjustment Of Mortgage Loans Held For Sale
FairValueAdjustmentOfMortgageLoansHeldForSale
-3975000 usd
CY2024Q1 mho Additions Of Servicing Asset
AdditionsOfServicingAsset
-1127000 usd
CY2023Q1 mho Additions Of Servicing Asset
AdditionsOfServicingAsset
-1390000 usd
CY2024Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
355000 usd
CY2023Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
523000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
3304000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
3214000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
808000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
660000 usd
CY2024Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
2613000 usd
CY2023Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3539000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2023000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15775000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-175316000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3808000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4564000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20294000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-20171000 usd
CY2024Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
7388000 usd
CY2023Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
4682000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-40047000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-38969000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
32561000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
11206000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
115772000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
251499000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
276000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2079000 usd
CY2024Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
23685000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
2714000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
6853000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17108000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4793000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
58477000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-22123000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25278000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5495000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6439000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38694000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15684000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
137358000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
231022000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
732804000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311542000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
870162000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
7788000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8458000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
683000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
838000 usd
CY2024Q1 mho Community Development District Infrastructure
CommunityDevelopmentDistrictInfrastructure
-2215000 usd
CY2023Q1 mho Community Development District Infrastructure
CommunityDevelopmentDistrictInfrastructure
-2641000 usd
CY2024Q1 mho Consolidated Inventory Not Owned Obligation
ConsolidatedInventoryNotOwnedObligation
-12291000 usd
CY2023Q1 mho Consolidated Inventory Not Owned Obligation
ConsolidatedInventoryNotOwnedObligation
2600000 usd
CY2024Q1 mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
8550000 usd
CY2023Q1 mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
5244000 usd
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Unaudited Condensed Consolidated Financial Statements (the “financial statements”) of M/I Homes, Inc. and its subsidiaries (the “Company”) and notes thereto have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. The financial statements include the accounts of the Company. All intercompany transactions have been eliminated. Results for the interim period are not necessarily indicative of results for a full year. In the opinion of management, the accompanying financial statements reflect all adjustments (all of which are normal and recurring in nature) necessary for a fair presentation of financial results for the interim periods presented. These financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that period. Actual results could differ from these estimates and have a significant impact on the financial condition and results of operations and cash flows. With regard to the Company, estimates and assumptions are inherent in calculations relating to valuation of inventory and investment in unconsolidated joint ventures, property and equipment depreciation, valuation of derivative financial instruments, accounts payable on inventory, accruals for costs to complete inventory, accruals for warranty claims, accruals for self-insured general liability claims, litigation, accruals for health care and workers’ compensation, accruals for guaranteed or indemnified loans, stock-based compensation expense, income taxes, and contingencies. Items that could have a significant impact on these estimates and assumptions include the risks and uncertainties listed in “Item 1A. Risk Factors” in Part I of our 2023 Form 10-K, as the same may be updated from time to time in our subsequent filings with the SEC. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of New Accounting Standards and SEC Guidance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2023-07”). ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. The amendments in this update also expand the interim segment disclosure requirements. ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023, and interim reporting periods in fiscal years beginning after December 31, 2024. The Company is currently evaluating the impact the adoption of ASU 2023-07 may have on our consolidated financial statements and disclosures, but we do not expect the impact to be significant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2023-09”). ASU 2023-09 requires public companies to annually (1) disclose specific categories in the income tax rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than five percent of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate). ASU 2023-09 will be effective for the annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact the adoption of ASU 2023-09 may have on our consolidated financial statements and disclosures, but we do not expect the impact to be significant.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC issued Final Rule Release No. 33-11275, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Enhancement and Standardization of Climate-Related Disclosures for Investors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This rule will require registrants to disclose certain climate-related information in registration statements and annual reports. The rules require information about a registrant’s climate-related risks that are reasonably likely to have a material impact on its business, results of operations, or financial condition. The required information about climate-related risks will also include disclosure of a registrant’s greenhouse gas emissions. In addition, the rules will require registrants to present certain climate-related financial metrics in their audited financial statements. These requirements are effective for the Company in various fiscal years, starting with the disclosure requirements in the Company's fiscal year beginning January 1, 2025. Disclosures will be required prospectively, with information for prior periods required only to the extent it was previously disclosed in an SEC filing. The Company is currently evaluating the final rule to determine its impact on the Company's </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosures. The Rule is currently the subject of litigation in the 8th Circuit Court of Appeals. On April 4, 2024, the SEC voluntarily stayed the implementation of the Rule pending completion of the litigation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our significant accounting policies during the quarter ended March 31, 2024 as compared to those disclosed in our 2023 Form 10-K.</span></div>
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1448459000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1446576000 usd
CY2024Q1 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
136000 usd
CY2023Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
6932000 usd
CY2024Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1169791000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1177101000 usd
CY2024Q1 mho Model Home Accumulated Depreciation
ModelHomeAccumulatedDepreciation
11120000 usd
CY2023Q4 mho Model Home Accumulated Depreciation
ModelHomeAccumulatedDepreciation
10940000 usd
CY2024Q1 mho Inventory Model Homes And Furnishings
InventoryModelHomesAndFurnishings
72567000 usd
CY2023Q4 mho Inventory Model Homes And Furnishings
InventoryModelHomesAndFurnishings
68696000 usd
CY2024Q1 mho Community Development District
CommunityDevelopmentDistrict
17124000 usd
CY2023Q4 mho Community Development District
CommunityDevelopmentDistrict
19339000 usd
CY2024Q1 mho Land Purchase Deposits
LandPurchaseDeposits
51480000 usd
CY2023Q4 mho Land Purchase Deposits
LandPurchaseDeposits
51608000 usd
CY2024Q1 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
14608000 usd
CY2023Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
26899000 usd
CY2024Q1 us-gaap Inventory Real Estate
InventoryRealEstate
2774165000 usd
CY2023Q4 us-gaap Inventory Real Estate
InventoryRealEstate
2797151000 usd
CY2024Q1 mho Number Of Speculative Homes
NumberOfSpeculativeHomes
1896 homes
CY2024Q1 mho Speculative Homes Carrying Value
SpeculativeHomesCarryingValue
366900000 usd
CY2023Q4 mho Number Of Speculative Homes
NumberOfSpeculativeHomes
2023
CY2023Q4 mho Speculative Homes Carrying Value
SpeculativeHomesCarryingValue
424200000 usd
CY2024Q1 mho Community Development District
CommunityDevelopmentDistrict
17100000 usd
CY2023Q4 mho Community Development District
CommunityDevelopmentDistrict
19300000 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
32144000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
29625000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
8950000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
9024000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8302000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8040000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
32792000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
30609000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
2030000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
7635000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
59100000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
44000000 usd
CY2024Q1 mho Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements
Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements
15100000 usd
CY2024Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
23700000 usd
CY2024Q1 mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
8600000 usd
CY2024Q1 mho Companysinvestmentinjointdevelopmentorsimilaragreements
Companysinvestmentinjointdevelopmentorsimilaragreements
53500000 usd
CY2023Q4 mho Companysinvestmentinjointdevelopmentorsimilaragreements
Companysinvestmentinjointdevelopmentorsimilaragreements
38400000 usd
CY2024Q1 mho Equityinvestedin Ll Cs
EquityinvestedinLLCs
5600000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
59100000 usd
CY2024Q1 mho Notional Amount Of Uncommitted Interest Rate Lock Commitments
NotionalAmountOfUncommittedInterestRateLockCommitments
215306000 usd
CY2023Q4 mho Notional Amount Of Uncommitted Interest Rate Lock Commitments
NotionalAmountOfUncommittedInterestRateLockCommitments
174274000 usd
CY2024Q1 mho Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments
ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments
217000000 usd
CY2023Q4 mho Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments
ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments
174000000 usd
CY2024Q1 mho Best Effort Contracts And Related Mortgage Loans Held For Sale
BestEffortContractsAndRelatedMortgageLoansHeldForSale
7797000 usd
CY2023Q4 mho Best Effort Contracts And Related Mortgage Loans Held For Sale
BestEffortContractsAndRelatedMortgageLoansHeldForSale
10398000 usd
CY2024Q1 mho Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale
ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale
209000000 usd
CY2023Q4 mho Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale
ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale
152000000 usd
CY2024Q1 mho Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities
MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities
225360000 usd
CY2023Q4 mho Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities
MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities
160547000 usd
CY2024Q1 mho Gain Loss On Assets And Liabilities Measured On Recurring Basis
GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis
2643000 usd
CY2023Q1 mho Gain Loss On Assets And Liabilities Measured On Recurring Basis
GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis
8328000 usd
CY2024Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Asset
EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset
2778000 usd
CY2024Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1224000 usd
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Asset
EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset
3617000 usd
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
7555000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2024Q1 mho Total Of Loans Covered By Guarantees
TotalOfLoansCoveredByGuarantees
531300000 usd
CY2023Q4 mho Total Of Loans Covered By Guarantees
TotalOfLoansCoveredByGuarantees
544500000 usd
CY2024Q1 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
4300000 usd
CY2023Q4 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
6300000 usd
CY2024Q1 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
1200000 usd
CY2023Q4 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
1700000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
31980000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
32902000 usd
CY2024Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5599000 usd
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5373000 usd
CY2024Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
22000 usd
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
643000 usd
CY2024Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
5338000 usd
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
5725000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
32263000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
33193000 usd
CY2024Q1 mho Letters Of Credit And Bonds
LettersOfCreditAndBonds
438700000 usd
CY2024Q1 mho Outstanding Performance Bonds
OutstandingPerformanceBonds
360700000 usd
CY2024Q1 mho Performance Letters Of Credit Outstanding
PerformanceLettersOfCreditOutstanding
59400000 usd
CY2024Q1 mho Financial Letters Of Credit
FinancialLettersOfCredit
11500000 usd
CY2024Q1 mho Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Contracts
OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionContracts
11000000 usd
CY2024Q1 mho Financial Bonds
FinancialBonds
4600000 usd
CY2024Q1 mho Corporate Notes
CorporateNotes
2500000 usd
CY2024Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
1130000000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1000000 usd
CY2024Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
2030000000.00 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 mho Letters Of Credit Outstanding Under Credit Facility
LettersOfCreditOutstandingUnderCreditFacility
70800000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
579200000 usd
CY2024Q1 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
240000000 usd
CY2023Q4 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
300000000 usd
CY2024Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
224300000 usd
CY2023Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
165800000 usd
CY2024Q1 us-gaap Equity Restrictions
EquityRestrictions
852500000 usd
CY2023Q4 us-gaap Equity Restrictions
EquityRestrictions
813700000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
138061000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
103066000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28052000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27602000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
836000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
703000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28888000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28305000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.92
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.73
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.78
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.64
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
266000 shares
CY2024Q1 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
600000 usd
CY2023Q1 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
900000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42200000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32900000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234 rate
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242 rate
CY2024Q1 us-gaap Revenues
Revenues
1046703000 usd
CY2023Q1 us-gaap Revenues
Revenues
1000530000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
173319000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
134586000 usd
CY2024Q1 mho Interest Income Net Of Interest Expense
InterestIncomeNetOfInterestExpense
6920000 usd
CY2023Q1 mho Interest Income Net Of Interest Expense
InterestIncomeNetOfInterestExpense
1389000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
180239000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
135982000 usd
CY2024Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
51480000 usd
CY2024Q1 mho Inventory Segments
InventorySegments
2722685000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
59146000 usd
CY2024Q1 mho Other Combined Assets
OtherCombinedAssets
1378640000 usd
CY2024Q1 us-gaap Assets
Assets
4211951000 usd
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
51608000 usd
CY2023Q4 mho Inventory Segments
InventorySegments
2745543000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
44011000 usd
CY2023Q4 mho Other Combined Assets
OtherCombinedAssets
1181278000 usd
CY2023Q4 us-gaap Assets
Assets
4022440000 usd
CY2021Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2022Q1 mho Stock Repurchase Program Authorized Amount Increasedecrease
StockRepurchaseProgramAuthorizedAmountIncreasedecrease
100000000 usd
CY2023Q4 mho Stock Repurchase Program Authorized Amount Increasedecrease
StockRepurchaseProgramAuthorizedAmountIncreasedecrease
100000000 usd
CY2024Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25300000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
102500000 usd
CY2024Q1 us-gaap Revenues
Revenues
1046703000 usd
CY2023Q1 us-gaap Revenues
Revenues
1000530000 usd
CY2024Q1 us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
-2900000 usd
CY2023Q1 us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
4200000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4211261 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
974452 shares
CY2024Q1 mho Percentageweightof Ps Usrelatedtoperformancecondition
PercentageweightofPSUsrelatedtoperformancecondition
0.80 rate
CY2024Q1 mho Percentageweightof Ps Usrelatedtomarketcondition
PercentageweightofPSUsrelatedtomarketcondition
0.20 rate
CY2024Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd

Files In Submission

Name View Source Status
0000799292-24-000039-index-headers.html Edgar Link pending
0000799292-24-000039-index.html Edgar Link pending
0000799292-24-000039.txt Edgar Link pending
0000799292-24-000039-xbrl.zip Edgar Link pending
exhibit22guarantors3-31x20.htm Edgar Link pending
exhibit311ceocertification.htm Edgar Link pending
exhibit312cfocertification.htm Edgar Link pending
exhibit321ceocertification.htm Edgar Link pending
exhibit322cfocertification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mho-20240331.htm Edgar Link pending
mho-20240331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
mho-20240331_def.xml Edgar Link unprocessable
mho-20240331_lab.xml Edgar Link unprocessable
mho-20240331_pre.xml Edgar Link unprocessable
mho-20240331_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mho-20240331_cal.xml Edgar Link unprocessable